Establishes pharmacist licensing exemption for certain dialysis-related drugs and devices.

This bill exempts drug manufacturers and wholesale distributors from needing a pharmacist license when distributing dialysate drugs and devices for home dialysis treatment. It directly affects patients with end-stage renal disease who use home dialysis systems, as well as manufacturers and distributors of these specific medical supplies. The exemption applies only if the drugs/devices are FDA-approved, delivered in original sealed packaging with a physician's order, and delivered directly to patients, their designees, or healthcare providers. Manufacturers must also contract with a licensed pharmacist for weekly quality assurance checks on storage and distribution. This change streamlines access to home dialysis supplies while maintaining safety oversight.